NSE · VITAL
Vital Chemtech Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹44 Cr with net profit ₹2 Cr — a 4.83% net margin, versus 0.8% the period before.
Shareholding
As of 2026-09-30
- Promoter73.43%
- Public24.7%
- FII1.62%
- DII0.25%
2,130 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.96× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #112 of 161 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,68,384 Cr | 74.39 | 21.93 | 29.5% | 17.7% |
| Pidilite Industries Ltd. | ₹1,60,827 Cr | 59.92 | 14.32 | 23.94% | 16.63% |
| SRF Ltd. | ₹72,932 Cr | 30.88 | 4.81 | 14.92% | 12.76% |
| Linde India Limited | ₹58,496 Cr | 118.36 | 13.32 | 11.26% | 18.08% |
| Gujarat Fluorochemicals Ltd. | ₹51,251 Cr | 75.18 | 6.1 | 7.97% | 11.43% |
| Navin Fluorine International Ltd. | ₹46,234 Cr | 50.46 | 10.36 | 20.41% | 22.4% |
| Godrej Industries Ltd. | ₹32,198 Cr | 26.32 | 2.88 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹28,667 Cr | 33.54 | 5.59 | 16.65% | 15.28% |
| Deepak Nitrite Ltd. | ₹20,917 Cr | 19.53 | 3.23 | 16.4% | 10.9% |
| Aether Industries Limited | ₹20,731 Cr | 82.24 | 7.99 | 9.61% | 19.21% |
| Vital Chemtech Limited(this company) | ₹124 Cr | 49.85 | 1.25 | 1.03% | 1.72% |
AI analysis
AI-generated · google/gemini-2.5-flashVital Chemtech Limited operates with a market capitalization of Rs 119 Cr. The company reported revenue of Rs 135.98 Cr, with a profit margin of 96.3% and earnings per share (EPS) of Rs 0.43. Its book value stands at Rs 41.48 per share, with a debt-to-equity ratio of 0.42.
Positives
- +The company reported a high profit margin of 96.3%.
- +Revenue growth for the latest period was 36.3%.
- +Return on equity (ROE) is significantly high at 103.4%.
- +The debt-to-equity ratio is relatively low at 0.42.
- +Promoter holding remains high at 73.4309% as of June 30, 2026 without any pledges.
Negatives
- −The company reported a negative net profit of Rs -1.3023 Cr for the period ending March 2024.
- −The Earnings Per Share (EPS) for the latest period is low at Rs 0.43.
- −The price-to-earnings (PE) ratio is 115.72, which is high.
- −Return on Capital Employed (ROCE) is relatively low at 7.53%.
- −Public shareholding has increased from 0% in November 2022 to 24.7003% in June 2026, suggesting dilution from the original promoter holding.
Financial performance
Vital Chemtech Limited's revenue grew by 36.3% to Rs 135.98 Cr. The company's net profit was Rs 4.0559 Cr for the period ending March 2025. Annual revenue for March 2024 was Rs 101.6059 Cr, with a net loss of Rs 1.3023 Cr. Quarterly revenue for March 2026 was Rs 35.14 Cr, generating a net profit of Rs 0.84 Cr.
Profitability & returns
The company recorded a profit margin of 96.3%. Return on equity (ROE) was 103.4%, while return on capital employed (ROCE) stood at 7.53%. The EPS for the latest period was Rs 0.43. For March 2024, the company recorded a negative EPS of Rs -0.54.
Balance sheet
Vital Chemtech Limited has a debt-to-equity ratio of 0.42. The book value per share is Rs 41.48. No dividend yield was reported for the company. The company's market capitalization is Rs 119 Cr.
Ownership & pledges
Total institutional holding is 1.8688%. There are no reported promoter pledges.
Regulatory & surveillance
Vital Chemtech Limited is listed under the Exchange Surveillance Measure (ESM) framework, specifically 'ESM · ESM 2'. This indicates the company is subject to specific surveillance measures by the exchange.
Data as of — price: 2026-11-07 · financials: Jun 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.